| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Animal: DNA Viruses |
Department of Virology, Ludwig Institute for Cancer Research, R. Prof. Antonio Prudente 109, 4 Andar, 01509-010 São Paulo, SP, Brazil1
Department of Pathology, Jewish General Hospital, 3755 Cote-Ste-Catherine Road, Montreal, CanadaH3T 1E22
Public Health Sciences Department, University of Toronto, 12 Queen’s Park Crescent West, Toronto, Ontario, CanadaM5S 1A83
Departments of Epidemiology and Oncology, McGill University, 546 Pine Avenue West, Montreal, CanadaH2W 1S64
Department of Biochemistry, Chemistry Institute5 and Department of Microbiology6, University of São Paulo, Cidade Universitária, São Paulo, CP20.780, Brazil
Author for correspondence: Luisa Villa. Fax +55 11 270 7001. e-mail llvilla{at}node1.com.br
In order to determine geographically related intratypic variation in human papillomavirus (HPV) type 16 and 18 isolates that could be associated with lesion development, data were analysed from an ongoing cohort study of the natural course of infection of HPVs and cervical neoplasia. Testing for HPVs was carried out by PCR and molecular variants of these HPVs were characterized by sequence analysis of the long control region and by dot blot hybridization of the E6 and L1 genes. Tests for HPV were done in multiple first-year specimens from 1690 women enrolled in a cancer screening program from 1993 to 1997. Subjects were followed-up by cytology and cervicography for detection of cervical lesions. Seven variants of HPV-16 and four of HPV-18 were detected in one or more specimens from 65 subjects. The same variant was found in specimens taken on different visits from each case of persistent infection. Overall, non-European variants tended to persist more frequently [odds ratio (OR)=4·5; 95% confidence interval (CI), 1·6–12·4] than European (E) variants (OR=2·5; 95% CI, 1·3–4·9), relative to the risk of persistence for non-oncogenic HPVs. In addition, non-E variants were more strongly associated with risk of both prevalent (age- and race-adjusted OR=172·2; 95% CI, 47·1–630·1) and incident [relative risk (RR)=22·5; 95% CI, 6·0–83·9] high-grade lesions than E variants (prevalent lesions OR=46·3; 95% CI, 15·5–138·0 and incident lesons RR=6·1; 95% CI, 1·3–27·4), relative to the risk for HPV-negative women. Although consistent, the latter differences were not statistically significant. If confirmed in other populations, measurement of intratypic variation of HPV-16 and -18 has the potential to serve as an ancillary tool in cervical cancer screening.
This article has been cited by other articles:
|
|
 |
|
  S. Pande, N. Jain, B. K. Prusty, S. Bhambhani, S. Gupta, R. Sharma, S. Batra, and B. C. Das Human Papillomavirus Type 16 Variant Analysis of E6, E7, and L1 Genes and Long Control Region in Biopsy Samples from Cervical Cancer Patients in North India J. Clin. Microbiol., March 1, 2008; 46(3): 1060 - 1066. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. F. Xi, L. A. Koutsky, A. Hildesheim, D. A. Galloway, C. M. Wheeler, R. L. Winer, J. Ho, and N. B. Kiviat Risk for High-Grade Cervical Intraepithelial Neoplasia Associated with Variants of Human Papillomavirus Types 16 and 18 Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 4 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J P A Baak, A-J Kruse, S J Robboy, E A M Janssen, B van Diermen, and I Skaland Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers J. Clin. Pathol., October 1, 2006; 59(10): 1017 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. F. Xi, N. B. Kiviat, A. Hildesheim, D. A. Galloway, C. M. Wheeler, J. Ho, and L. A. Koutsky Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J Natl Cancer Inst, August 2, 2006; 98(15): 1045 - 1052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wu, Y. Chen, L. Li, G. Yu, Y. He, and Y. Zhang Analysis of mutations in the E6/E7 oncogenes and L1 gene of human papillomavirus 16 cervical cancer isolates from China. J. Gen. Virol., May 1, 2006; 87(Pt 5): 1181 - 1188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Grodzki, G. Besson, C. Clavel, A. Arslan, S. Franceschi, P. Birembaut, M. Tommasino, and I. Zehbe Increased Risk for Cervical Disease Progression of French Women Infected with the Human Papillomavirus Type 16 E6-350G Variant. Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 820 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. E. Calleja-Macias, L. L. Villa, J. C. Prado, M. Kalantari, B. Allan, A.-L. Williamson, L.-P. Chung, R. J. Collins, R. E. Zuna, S. T. Dunn, et al. Worldwide Genomic Diversity of the High-Risk Human Papillomavirus Types 31, 35, 52, and 58, Four Close Relatives of Human Papillomavirus Type 16 J. Virol., November 1, 2005; 79(21): 13630 - 13640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. F. Schlecht, R. D. Burk, J. M. Palefsky, H. Minkoff, X. Xue, L. S. Massad, M. Bacon, A. M. Levine, K. Anastos, S. J. Gange, et al. Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women J. Gen. Virol., October 1, 2005; 86(10): 2709 - 2720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Fontaine, P. Gravitt, L.-M. Duh, J. Lefevre, K. Pourreaux, C. Hankins, F. Coutlee, and The Canadian Women's HIV Study Group High Level of Correlation of Human Papillomavirus-16 DNA Viral Load Estimates Generated by Three Real-time PCR Assays Applied on Genital Specimens Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2200 - 2207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Chen, M. Terai, L. Fu, R. Herrero, R. DeSalle, and R. D. Burk Diversifying Selection in Human Papillomavirus Type 16 Lineages Based on Complete Genome Analyses J. Virol., June 1, 2005; 79(11): 7014 - 7023. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. G. Hubert Variant Upstream Regulatory Region Sequences Differentially Regulate Human Papillomavirus Type 16 DNA Replication throughout the Viral Life Cycle J. Virol., May 15, 2005; 79(10): 5914 - 5922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Li, D. S. Gerhard, Z. Zhang, P. C. Huettner, J. Wright, L. Nguyen, D. Lu, and J. S. Rader Denaturing High-Performance Liquid Chromatography for Detecting and Typing Genital Human Papillomavirus J. Clin. Microbiol., December 1, 2003; 41(12): 5563 - 5571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Burk, M. Terai, P. E. Gravitt, L. A. Brinton, R. J. Kurman, W. A. Barnes, M. D. Greenberg, O. C. Hadjimichael, L. Fu, L. McGowan, et al. Distribution of Human Papillomavirus Types 16 and 18 Variants in Squamous Cell Carcinomas and Adenocarcinomas of the Cervix Cancer Res., November 1, 2003; 63(21): 7215 - 7220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Molano, A. van den Brule, M. Plummer, E. Weiderpass, H. Posso, A. Arslan, C. J. L. M. Meijer, N. Munoz, and S. Franceschi Determinants of Clearance of Human Papillomavirus Infections in Colombian Women with Normal Cytology: A Population-based, 5-Year Follow-up Study Am. J. Epidemiol., September 1, 2003; 158(5): 486 - 494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Wang and A. Hildesheim Chapter 5: Viral and Host Factors in Human Papillomavirus Persistence and Progression J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 35 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. F. Xi, J. J. Carter, D. A. Galloway, J. Kuypers, J. P. Hughes, S. K. Lee, D. E. Adam, N. B. Kiviat, and L. A. Koutsky Acquisition and Natural History of Human Papillomavirus Type 16 Variant Infection among a Cohort of Female University Students Cancer Epidemiol. Biomarkers Prev., April 1, 2002; 11(4): 343 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F X Bosch, A Lorincz, N Munoz, C J L M Meijer, and K V Shah The causal relation between human papillomavirus and cervical cancer J. Clin. Pathol., April 1, 2002; 55(4): 244 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. F. Schlecht, S. Kulaga, J. Robitaille, S. Ferreira, M. Santos, R. A. Miyamura, E. Duarte-Franco, T. E. Rohan, A. Ferenczy, L. L. Villa, et al. Persistent Human Papillomavirus Infection as a Predictor of Cervical Intraepithelial Neoplasia JAMA, December 26, 2001; 286(24): 3106 - 3114. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
